Mark Hahn – Biography
Last update: 2 days agoExecutive profile
Mark was Chief Financial Officer at Verona Pharma, and Chief Financial Officer at Dova Pharmaceuticals. Mark Hahn joined Slate Medicines in 2026.
Mark Hahn is currentlyDirector at Slate Medicines - View - Slate Medicines org chart
Create your alert
to follow the career of Mark Hahn.
More about Mark Hahn
Selected links
Do you need to know more about Mark Hahn? More results.
Participate
Social media
- Mark Hahn on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Mark Hahn
The colleagues of Mark Hahn
Company Colleagues
- At Slate Medicines, Mark Hahn has 8 colleagues including Gregory Oakes (CEO), Peter Kolchinsky (Director)…
Homonyms
- Markus Hahn - Managing Director, Canada - Butting
- Mark Hahn - Human Resources Director - Holiday Stationstores
- Markus Hahn - Chief Technology Officer and Director of Hybrid Cloud - Logicalis Germany
- Mark Hahn - Senior Vice President, Portfolio Management - Waterton
- View all the 4 org charts > Close
Industry Colleagues
- In the Biotechnology industry, Mark Hahn has 35,936 colleagues in 2,429 companies located in 45 countries. 16,997 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Get in Touch
Here are a few tips for establishing great contacts.
Through the switchboard, call Slate Medicines at +1 509... and ask for Mark Hahn.
